Audit Committee Chair Under Pressure on a Related-Party Warehouse Lease
You chair the audit committee of a listed auto-components manufacturer with revenue of ₹4,200 crore. The board has nine directors, five of them independent. Management asks the committee to approve, by circulation, a nine-year lease of a warehouse from Sunrise Logistics, whose 60% shareholder is the brother-in-law of independent director Mr. Rao. Annual rent is ₹2.8 crore, about 11% above the rent paid for a comparable nearby facility. No competitive bids were invited because the CFO says capacity is urgently needed before the festive season. The supporting papers include an arm's-length certificate from a valuer who is an affiliate of the statutory auditor. Mr. Rao has not submitted a written interest disclosure, though he mentioned the connection orally at a board dinner. The MD tells you that delay will hurt Q4 despatches and that the matter is routine. A large shareholder has separately messaged you asking whether the lease was competitively priced. The committee must decide within 48 hours.
1. Evaluate whether the lease is a related-party transaction requiring audit committee scrutiny, and identify the governance defects in the papers placed before the committee.
Read the worked answer
The lease is plainly a related-party transaction. Mr. Rao is a director, and his brother-in-law is a relative under the Companies Act, 2013; an entity in which that relative holds a controlling stake is therefore connected to a director. Under SEBI LODR, material related-party transactions require prior audit committee approval, and even transactions claimed to be in the ordinary course need committee review and arm's-length assurance. The defects are substantive, not merely procedural. First, there is no competitive process, so the 11% premium is unexplained. Second, the valuer is an affiliate of the statutory auditor, which compromises independence and creates a self-review risk. Third, Mr. Rao has not made a written disclosure, and the oral mention at dinner is inadequate for minutes or recusal. Fourth, approval by circulation for a conflicted, material transaction suppresses deliberation. Fifth, the MD's urgency framing is pressure, not a governance rationale. The committee should not treat the papers as complete. It should defer, require an independent valuation from an unrelated firm, obtain market comparables, record Mr. Rao's interest, and ensure he recuses himself from discussion and vote. If the transaction is material, shareholder approval and detailed disclosure should be planned.
2. What process should you, as chair, follow before the committee reaches a decision? Address documentation, conflict management and escalation.
Read the worked answer
The chair should convert an under-prepared circulation into a properly convened, minuted meeting. Before the meeting, obtain the draft lease, the full commercial case, Mr. Rao's written interest disclosure, a market-rent benchmarking study, and a valuation from a valuer with no audit, advisory or referral relationship with the company or the statutory auditor. Ask management to explain in writing why no tender was run and whether a shorter lease or alternative site was considered. Circulate the papers to all committee members at least 48 hours in advance, flagging the conflict prominently. At the meeting, invite Mr. Rao to state his interest and then recuse himself; he should not receive the committee's confidential discussion. The CFO and statutory auditor should be questioned separately on the arm's-length certificate. The committee should record its reasoning, including any dissent, and approve only if the rent is benchmarked and the terms are demonstrably no worse than market. If the committee is not satisfied, it should reject or defer and escalate to the full board. The chair should also inform the company secretary so that disclosure obligations and insider-trading controls are considered. Finally, the chair should reply to the shareholder without disclosing unpublished price-sensitive information.
3. The MD argues that approval by circulation is permitted and necessary to meet the Q4 deadline. How should the chair respond, and what are the wider risks?
Read the worked answer
Permissibility is not the test. A circulation may be legally possible for routine matters, but using it for a material related-party transaction with an undisclosed director conflict undermines the committee's ability to deliberate, question management and record dissent. The chair should refuse circulation and convene a meeting, even if that means a short delay. The Q4 deadline is a commercial convenience; an avoidable conflict-of-interest failure is a governance and disclosure risk that can trigger regulatory scrutiny, related-party disclosure, and reputational damage with shareholders and proxy advisers. There is also an insider-trading dimension: if the lease is material and the shareholder has already asked about pricing, any selective briefing or hasty approval could create a market-abuse risk. The chair should tell the MD that the committee will act promptly once it has an independent valuation and a complete conflict declaration, and that management should not communicate a decision externally before the committee and, if required, shareholders approve. The minutes should record that circulation was declined and why. If management persists, the chair should escalate to the board chair and the nomination and remuneration committee, and consider whether the audit committee's terms of reference require a formal report to the board.